We previously reported that ZEB1/2 are positively correlated with the expression of mesenchymal marker proteins and the aggressiveness of various types of cancer cells, including those from human HNSCC and human breast cancer (Horiguchi et al., 2012; Sakamoto et al., 2021). This evidence concerns the gene ZEB1 and breast cancer.